PeptideStack
5.2kquestions
20kanswers
220users

Is AST a better monitoring choice than ALT on mazdutide?

Asked 12 Feb 2025Modified 14 months agoViewed 21k times
16

The case in front of me: AST · ALT · mazdutide.

The comparison I want does not seem to exist anywhere in a form I can evaluate.

I have read the arguments for each and they do not engage with each other.

Which axes does this decision turn on?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
kidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
liver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questions
mazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questions
shareeditfollowflag
SB
askedsamir_bennani15k2712 Feb 2025
Can you say how far out of range rather than that it was flagged? The flag is a threshold, not a finding. – bac_or_bust 23 days ago
add a comment

5 Answers

Accepted answer first, then by votes
67

Accepted answer

Answer first: decide what you would do differently for each possible result before you order the panel. Anything that fails that test is a number you will worry about and not act on.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Relative to absolute, worked

QuantityValueDerivation
Control-arm event rate8.0 %From the trial table, not the abstract
Hazard ratio0.80Reported
Treated event rate6.4 %8.0 × 0.80
Absolute risk reduction1.6 pp8.0 − 6.4
Number needed to treat631 ÷ 0.016
Relative risk reduction20 %1 − 0.80

The last two rows describe the same finding. Only one of them is used in headlines.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Reference intervals are conventionally the central ninety-five per cent of a reference population, which is the direct cause of the one-in-twenty out-of-range rate on a healthy panel.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
DF
answered · acceptedDr_Colm_Fitzhenry69k24721 Apr 2025
4Same experience here, different supplier. – low_dead_space 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
27

The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

shareimprove this answerflag
DA
answeredDr_Rosalind_Achebe69k14710 Apr 2025
Thank you — this is the answer I was looking for. – tyndall_haze 5 months ago
Delta checks against your own previous value are the part I had not thought about, and it reframes the whole panel. – Dr_Rosalind_Achebe 4 months ago
add a comment
18

This is answerable, and the answer is mostly about which tests rather than how many.

Delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

In practice, haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

edited 24 Apr 2025 by bufferline42 — clarified the distinction between purity and content

shareimprove this answerflag
BU
answeredbufferline4230k13830 Mar 2025
15

Standardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Decide the action for each result before you order the test.

shareimprove this answerflag
RM
answeredrosa_mendieta8k1619 Mar 2025
11

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

shareimprove this answerflag
DK
answeredDr_Sara_Kuusela28k375 Jun 2025
5Worth adding that the collection tube and how long the tourniquet was on move several of these analytes. – b_delacroix 9 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.